App-Based Cardiac Rehabilitation With Gamification or Peer Support in PCI Patients

Evaluating the effectiveness of Community-Based Cardiac Rehabilitation via an app with Gamification or Peer Support features on self-management and disease risk factors in PCI Patients: A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250927067378N1

Enrollment

258

Registered

2025-10-13

Start date

2026-02-20

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Coronary Artery Disease, post-Percutaneous Coronary Intervention (PCI). Condition 2: Ischemic Heart Disease. Condition 3: Cardiac Rehabilitation. Atherosclerotic heart disease of native coronary artery without angina pectoris Chronic ischemic heart disease, unspecified Encounter for other specified aftercare

Interventions

Intervention 1: Application-Based Intervention Group (Gamification Group): After the initial contact, patients are invited to the cardiac rehabilitation center to complete baseline information and med

Eligibility

Sex/Gender

All

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age between 40 and 65 years Patients diagnosed with coronary artery disease who have undergone PCI and have been discharged from Chamran Hospital within two weeks prior to enrollment. Patients identified as low-risk by a cardiologist, eligible for home-based rehabilitation, and unwilling to participate in center-based programs. Possession of and ability to use a smartphone and the study application. Willingness to provide written informed consent and comply with the study protocol.

Exclusion criteria

Exclusion criteria: Patients with contraindications for exercise (such as untreated ventricular tachycardia, severe heart failure, left ventricular ejection fraction >45%, uncontrolled hypertension, or cognitive impairments preventing exercise). Inability to use the application due to physical or technological limitations. Concurrent participation in other clinical trials.

Design outcomes

Primary

Measure	Time frame
Patients' knowledge, attitude, and practice towards self-management of heart disease. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Knowledge, Attitude and Performance Questionnaire (CVD KAP 29 Checklist).;Patients' quality of life score. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: SF-36 questionnaire.;Physical activity score of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: International Physical Activity Questionnaire-short form: IPAQ- short form.;Patients' depression scores. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Patient Health Questionnaire-4.;Patients' anxiety scores. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Patient Health Questionnaire-4.;Patients' medication adherence score. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: General Medication Adherence Scale (GMAS).;Total cholesterol level. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;Patients' fasting blood sugar levels. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;The HDL blood level of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;The LDL blood level of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the l	—

Measure

Time frame

Patients' knowledge, attitude, and practice towards self-management of heart disease. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Knowledge, Attitude and Performance Questionnaire (CVD KAP 29 Checklist).;Patients' quality of life score. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: SF-36 questionnaire.;Physical activity score of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: International Physical Activity Questionnaire-short form: IPAQ- short form.;Patients' depression scores. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Patient Health Questionnaire-4.;Patients' anxiety scores. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: Patient Health Questionnaire-4.;Patients' medication adherence score. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: General Medication Adherence Scale (GMAS).;Total cholesterol level. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;Patients' fasting blood sugar levels. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;The HDL blood level of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the laboratory using a diagnostic kit.;The LDL blood level of patients. Timepoint: Before the start of the intervention and 6 months after the start of the intervention. Method of measurement: In the l

—

Secondary

Measure	Time frame
Nutritional status of patients. Timepoint: Before the start of the intervention and six months after the start of the intervention. Method of measurement: Using the nutritional checklist used in the SIB system and primary health care centers.;Number of cigarettes smoked daily by patients. Timepoint: Before the start of the intervention and six months after the start of the intervention. Method of measurement: Number of cigarettes smoked by patients in a day.	—

Measure

Time frame

Nutritional status of patients. Timepoint: Before the start of the intervention and six months after the start of the intervention. Method of measurement: Using the nutritional checklist used in the SIB system and primary health care centers.;Number of cigarettes smoked daily by patients. Timepoint: Before the start of the intervention and six months after the start of the intervention. Method of measurement: Number of cigarettes smoked by patients in a day.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ehsan Shirvani

Esfahan University of Medical Sciences

shirvani_xs100@yahoo.com+98 31 3611 5213

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026